Pharmacokinetics News and Research

RSS
The term pharmacokinetics is derived from the ancient Greek words “pharmakon” and “kinetikos”, meaning “drug” and “putting in motion” respectively. It is one of the main branches of pharmacology, and refers to the way that the body reacts on and affects a pharmaceutical substance in the body.

Further Reading

Civitas Therapeutics reports positive results from Phase 2 study of CVT-301 for Parkinson's disease

Civitas Therapeutics reports positive results from Phase 2 study of CVT-301 for Parkinson's disease

20 Apr 2013
Science behind medical acupuncture

Science behind medical acupuncture

17 Apr 2013
GlycoMimetics reports Phase 2 clinical study results of GMI-1070

GlycoMimetics reports Phase 2 clinical study results of GMI-1070

17 Apr 2013
Rhythm starts RM-131 Phase 2 clinical trial for treatment of chronic constipation

Rhythm starts RM-131 Phase 2 clinical trial for treatment of chronic constipation

16 Apr 2013
DelMar Pharmaceuticals reports positive results from VAL-083 Phase I/II clinical trial in patients with GBM

DelMar Pharmaceuticals reports positive results from VAL-083 Phase I/II clinical trial in patients with GBM

11 Apr 2013
Updated clinical data from phase I study of Ensituximab presented at AACR meeting

Updated clinical data from phase I study of Ensituximab presented at AACR meeting

11 Apr 2013
Galectin Therapeutics provides details on first-in-man Phase 1 clinical trial of GR-MD-02

Galectin Therapeutics provides details on first-in-man Phase 1 clinical trial of GR-MD-02

10 Apr 2013
Lipocine announces favorable Phase I study results for LPCN 1111

Lipocine announces favorable Phase I study results for LPCN 1111

8 Apr 2013
Phase 3 study results of simeprevir in hepatitis C patients to be presented at EASL Congress

Phase 3 study results of simeprevir in hepatitis C patients to be presented at EASL Congress

8 Apr 2013
Nektar Therapeutics presents positive results for NKTR-214 at AACR Annual Meeting

Nektar Therapeutics presents positive results for NKTR-214 at AACR Annual Meeting

8 Apr 2013
Arena Pharmaceuticals kicks off APD334 Phase 1 clinical trial for treatment of autoimmune diseases

Arena Pharmaceuticals kicks off APD334 Phase 1 clinical trial for treatment of autoimmune diseases

6 Apr 2013
Vertex to conduct two Phase 2 studies of VX-135 in combination with daclatasvir

Vertex to conduct two Phase 2 studies of VX-135 in combination with daclatasvir

6 Apr 2013
Isis Pharmaceuticals starts ISIS-APOARx Phase 1 clinical study for treatment of atherosclerosis

Isis Pharmaceuticals starts ISIS-APOARx Phase 1 clinical study for treatment of atherosclerosis

3 Apr 2013
Oncodesign signs agreement with Sanofi to identify kinase inhibitors involved in tissue protection and repair

Oncodesign signs agreement with Sanofi to identify kinase inhibitors involved in tissue protection and repair

27 Mar 2013
Researchers test protease inhibitors with potential for prevention, treatment of norovirus infection

Researchers test protease inhibitors with potential for prevention, treatment of norovirus infection

25 Mar 2013
arGEN-X advances ARGX-112 into formal preclinical development

arGEN-X advances ARGX-112 into formal preclinical development

25 Mar 2013
BioCryst starts BCX4161 Phase 1 clinical trial for treatment of hereditary angioedema

BioCryst starts BCX4161 Phase 1 clinical trial for treatment of hereditary angioedema

25 Mar 2013
Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

18 Mar 2013
Einstein researchers to develop drug-impregnated intravaginal ring for HIV prevention in women

Einstein researchers to develop drug-impregnated intravaginal ring for HIV prevention in women

11 Mar 2013
Armetheon plans to develop tecarfarin against prosthetic heart valves or chronic renal dysfunction

Armetheon plans to develop tecarfarin against prosthetic heart valves or chronic renal dysfunction

11 Mar 2013

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback